» Authors » Konstantin G Kousoulas

Konstantin G Kousoulas

Explore the profile of Konstantin G Kousoulas including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 90
Citations 1739
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Nabi R, Chouljenko V, Musarrat F, Davis M, Mohan H, Ghavimi R, et al.
J Med Virol . 2025 Feb; 97(2):e70220. PMID: 39930884
Oncolytic virotherapy (OVT) aims to disrupt the tumor microenvironment and provide a unique therapeutic approach against solid tumors. Herpes simplex virus type-1 (HSV-1) has shown strong promise for treating various...
2.
Rider P, Dulin H, Uche I, McGee M, Huang W, Kousoulas K, et al.
J Med Virol . 2024 Nov; 96(11):e70067. PMID: 39568407
Influenza virus is a major respiratory viral pathogen responsible for the deaths of hundreds of thousands worldwide each year. Current vaccines provide protection primarily by inducing strain-specific antibody responses with...
3.
Nasar R, Uche I, Kousoulas K
Curr Issues Mol Biol . 2024 Jun; 46(6):5582-5594. PMID: 38921005
The recent success of cancer immunotherapies, such as immune checkpoint inhibitor (ICIs), monoclonal antibodies (mAbs), cancer vaccines, and adoptive cellular therapies (ACTs), has revolutionized traditional cancer treatment. However, these immunotherapeutic...
4.
Stanfield B, Ruiz E, Chouljenko V, Kousoulas K
Virus Genes . 2024 Feb; 60(2):148-158. PMID: 38340271
Guinea Pig Herpes-Like Virus (GPHLV) is a virus isolated from leukemic guinea pigs with herpes virus-like morphology described by Hsiung and Kaplow in 1969. GPHLV transformed embryonic cells from Syrian...
5.
Zhang T, Magazine N, McGee M, Carossino M, Veggiani G, Kousoulas K, et al.
J Med Virol . 2024 Jan; 96(1):e29408. PMID: 38258331
Vaccines have demonstrated remarkable effectiveness in protecting against COVID-19; however, concerns regarding vaccine-associated enhanced respiratory diseases (VAERD) following breakthrough infections have emerged. Spike protein subunit vaccines for SARS-CoV-2 induce VAERD...
6.
Zhang T, Magazine N, McGee M, Carossino M, Veggiani G, Kousoulas K, et al.
bioRxiv . 2023 Oct; PMID: 37904941
Vaccines have demonstrated remarkable effectiveness in protecting against COVID-19; however, concerns regarding vaccine-associated enhanced respiratory diseases (VAERD) following breakthrough infections have emerged. Spike protein subunit vaccines for SARS-CoV-2 induce VAERD...
7.
Singha M, Pu L, Srivastava G, Ni X, Stanfield B, Uche I, et al.
Cancers (Basel) . 2023 Aug; 15(16). PMID: 37627077
Deregulated protein kinases are crucial in promoting cancer cell proliferation and driving malignant cell signaling. Although these kinases are essential targets for cancer therapy due to their involvement in cell...
8.
Nabi R, Musarrat F, Menk P Lima J, Langohr I, Chouljenko V, Kousoulas K
Front Mol Biosci . 2023 Jun; 10:1199068. PMID: 37388243
Oncolytic viruses (OVs) provide new modalities for cancer therapy either alone or in combination with synergistic immunotherapies and/or chemotherapeutics. Engineered Herpes Simplex Virus Type-1 (HSV-1) has shown strong promise for...
9.
Withers S, Moeller C, Quick C, Liu C, Baham S, Looper J, et al.
PLoS One . 2023 Apr; 18(4):e0284645. PMID: 37079538
Cancer cell-intrinsic mechanisms affecting radiation immunomodulation could be exploited to optimize systemic effects of localized radiation. Radiation-induced DNA damage is sensed by cyclic GMP-AMP synthase (cGAS), which ultimately activates stimulator...
10.
Clark C, Jambunathan N, Collantes T, Kousoulas K
Viruses . 2023 Feb; 15(2). PMID: 36851581
The HSV-1 (VC2) live-attenuated vaccine strain was engineered with specific deletions in the amino termini of glycoprotein K (gK) and membrane protein UL20, rendering the virus unable to enter neurons...